Posts tagged as:

severe ulcerative colitis treatment

ulcerative-colitis-drug-remedyOn May 20, 2014, Takeda Pharmaceutical Company Limited and the FDA announced vedolizumab as a treatment option for moderate to severe ulcerative colitis (UC) and Crohn’s disease (CD) for adults whose illness did not respond to or tolerate other treatment options.

Specifically, the labeling for this monoclonal antibody therapy indicates it is for use with UC or CD patients who did not adequately respond to tumor necrosis factor (TNF) blocker or immunomodulator or to corticosteroid therapy treatments. [click to continue…]

{ 0 comments }

© RPh on the Go, All Rights Reserved.